Publikationen

Concordance between comprehensive cancer genome profiling in plasma and tumor specimens.

Müller JN, Falk M, Talwar J, Neemann N, Mariotti E, Bertrand M, Zacherle T, Lakis S, Menon R, Gloeckner C, Tiemann M, Heukamp LC, Thomas RK, Griesinger F, Heuckmann JM.
J Thorac Oncol. 2017 Jul 24. pii: S1556-0864(17)30611-1. doi: 10.1016/j.jtho.2017.07.014. [Epub ahead of print]
PMID: 28751246

Significance of syndecan-1 expression in ductal carcinoma in situ of the breast.

Tiemann K, Weigel MT, Alkatout I, Wenners AS, Mundhenke H, Schäfer FW, Bauer M, Schem C, Maass N, Jonat W, Mundhenke C.
Anticancer Res. 2014 Jul;34(7):3607-16.
PMID: 24982376

Final safety and efficacy analysis of a phase I/II trial with imatinib and vinorelbine for patients with metastatic breast cancer.

Maass N, Schem C, Bauerschlag DO, Tiemann K, Schaefer FW, Hanson S, Muth M, Baier M, Weigel MT, Wenners AS, Alkatout I, Bauer M, Jonat W, Mundhenke C.
Oncology. 2014;87(5):300-10. doi: 10.1159/000365553. Epub 2014 Aug 26.
PMID: 25171229

Multicolor immunofluorescence reveals that p63- and/or K5-positive progenitor cells contribute to normal breast epithelium and usual ductal hyperplasia but not to low-grade intraepithelial neoplasia of the breast.

Boecker W, Stenman G, Schroeder T, Schumacher U, Loening T, Stahnke L, Löhnert C, Siering RM, Kuper A, Samoilova V, Tiemann M, Korsching E, Buchwalow I.
Virchows Arch. 2017 May;470(5):493-504. doi: 10.1007/s00428-017-2073-7. Epub 2017 Mar 16.
PMID: 2830334

Characterization of mast cell populations using different methods for their identification.

Atiakshin D, Samoilova V, Buchwalow I, Boecker W, Tiemann M.
Histochem Cell Biol. 2017 Jun;147(6):683-694. doi: 10.1007/s00418-017-1547-7. Epub 2017 Feb 27.
PMID: 28243739

Oxidative stress and NO generation in the rat pancreatitis induced by pancreatic duct ligation.

Buchwalow I, Schnekenburger J, Atiakshin D, Samoilova V, Wolf E, Boecker W, Tiemann K.
Acta Histochem. 2017 Apr;119(3):252-256. doi: 10.1016/j.acthis.2017.01.010. Epub 2017 Feb 3.
PMID: 28168994

Immunohistochemical and molecular profile of salivary gland cancer in children.

Locati LD, Collini P, Imbimbo M, Barisella M, Testi A, Licitra LF, Löning T, Tiemann K, Quattrone P, Bimbatti E, Chiaravalli S, Casanova M, Tamborini E, Carta R, Gasparini P, Guzzo M, Massimino M, Ferrari A.
Pediatr Blood Cancer. 2017 Jan 31. doi: 10.1002/pbc.26468. [Epub ahead of print]
PMID: 28139061

Poster

Die MYD88 L265P-Mutation: Ein Werkzeug für die Differentialdiagnose von indolenten Lymphomen mit überlappenden klinisch-pathologischen Eigenschaften? Michael Preukschas Marina Lebherz, Cora Hallas, Markus Tiemann. Jahrestagung der Deutschen Gesellschaft für Hämatologie und Onkologie, 10.-14. Oktober 2014 Hamburg, Germany

Tumor-infiltrierende Lymphozyten in kolorektalen Adenokarzinomen:  Die Entwicklung der Immunantwort in den verschiedenen Tumorstadien. Merle Stamm, Cora Hallas, Markus Falk, Markus Tiemann. Jahrestagung der Deutschen Gesellschaft für Hämatologie und Onkologie, 10.-14. Oktober 2014 Hamburg, Germany

Distribution of driver mutations in a northern German cohort of melanoma patients and limitations of different methods for BRAF testing. Markus Falk, Tobias Berg, Hans-Joachim Schulze, Michael Fluck, Markus Tiemann 8th World Congress of Melanoma, July 17–20 2013, Hamburg, Germany

Incidence of molecular targets (EGFR-mutation, EML4-Alk, BRAF and KRAS) in metastatic NSCLC in a certified lung cancer hospital. Volker Halbfass, Markus Falk, Regina Prenzel, Hans-Georg Dercken, Douglas Scriba, Markus Tiemann, Frank Griesinger 14th Conference of Lung Cancer, 3-7 July 2011, Amsterdam, Netherlands

Various Mutations In JAK2 Exon 12 Induce Divergent Bone Marrow Alterations Hallas C, Schulte C, Heidorn K, Tiemann M 53 ASH Annual Meeting and Exposition 2011, Abstract 4096

to top icon